Drugs / Norethindrone/Ethinyl Estradiol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01340625 | Dec 2006 → Jan 2007 | — | Teva Pharmaceuticals USA | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Norethindrone/Ethinyl Estradiol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01340625 ↗ |
| Route | Oral | “following a single oral dose” NCT01340625 ↗ |